This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crook, E. D. Articles by Singh, L. P. Search for Related Content PubMed PubMed Citation Articles by Crook, E. D. Articles by Singh, L. P.

Overexpression of Glutamine:Fructose-6-Phosphate Amidotransferase in Rat-1 Fibroblasts Enhances Glucose-Mediated Glycogen Accumulation via Suppression of Glycogen Phosphorylase Activity¹

Department of Medicine, University of Mississippi Medical Center, and Veterans Administration Medical Center (E.D.C.), Jackson, Mississippi 39216

Address all correspondence and requests for reprints to: Errol D. Crook, M.D., Division of Nephrology, University of Mississippi Medical Center, 2500 North State Street, Jackson, Mississippi 39216. E-mail: ecrook{at}medicine.umsmed.edu

The hexosamine biosynthesis pathway (HBP) mediates many of the adverse effects of excess glucose. We have shown previously that glucose down-regulates basal and insulin-stimulated glycogen synthase (GS) activity. Overexpression of the rate-limiting enzyme in the HBP, glutamine:fructose-6-phosphate amidotransferase (GFA), mimics these effects of high glucose and renders the cells more sensitive to glucose. Here we examine the role of the HBP in regulating cellular glycogen content. Glycogen content and glycogen phosphorylase (GP) activity were determined in Rat-1 fibroblasts that overexpress GFA. In both GFA and controls there was a dose-dependent increase in glycogen content (8-fold) in cells cultured in increasing glucose concentrations (1–20 mM). There was a shift to the left in the glucose dose-response curve for glycogen content in GFA cells (ED₅₀ for glycogen content = 5.80 ± 1.05 vs. 8.84 ± 0.87 mM glucose, GFA vs. control). Inhibition of GFA reduced glycogen content by 28.4% in controls cultured in 20 mM glucose. In a dose-dependent manner, glucose resulted in a more than 35% decrease in GP activity in controls. GP activity in GFA cells was suppressed compared with that in controls, and there was no glucose-induced down-regulation of GP activity. Glucosamine and uridine mimicked the effects of glucose on glycogen content and GP activity. However, chronic overexpression of GFA is a unique model of hexosamine excess, as culturing control cells in low dose glucosamine (0.1–0.25 mM) did not suppress GP activity and did not eliminate the glucose-mediated down-regulation of GP activity. We conclude that increased flux through the HBP results in enhanced glycogen accumulation due to suppression of GP activity. These results demonstrate that the HBP is an important regulator of cellular glucose metabolism and supports its role as a cellular glucose/satiety sensor.

This article has been cited by other articles:

				C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF]

				L. P. Singh, K. Green, M. Alexander, S. Bassly, and E. D. Crook Hexosamines and TGF-{beta}1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells Am J Physiol Renal Physiol, February 1, 2004; 286(2): F409 - F416. [Abstract] [Full Text] [PDF]

				M.-J. J. Pouwels, P. N. Span, C. J. Tack, A. J. Olthaar, C. G. J. Sweep, B. G. van Engelen, J. G. de Jong, J. A. Lutterman, and A. R. Hermus Muscle Uridine Diphosphate-Hexosamines Do Not Decrease Despite Correction of Hyperglycemia-Induced Insulin Resistance in Type 2 Diabetes J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5179 - 5184. [Abstract] [Full Text] [PDF]

				M. Nakamura, A. J. Barber, D. A. Antonetti, K. F. LaNoue, K. A. Robinson, M. G. Buse, and T. W. Gardner Excessive Hexosamines Block the Neuroprotective Effect of Insulin and Induce Apoptosis in Retinal Neurons J. Biol. Chem., November 16, 2001; 276(47): 43748 - 43755. [Abstract] [Full Text] [PDF]

				L. P. Singh, J. Andy, V. Anyamale, K. Greene, M. Alexander, and E. D. Crook Hexosamine-Induced Fibronectin Protein Synthesis in Mesangial Cells Is Associated With Increases in cAMP Responsive Element Binding (CREB) Phosphorylation and Nuclear CREB: The Involvement of Protein Kinases A and C Diabetes, October 1, 2001; 50(10): 2355 - 2362. [Abstract] [Full Text]

				L. Rossetti Perspective: Hexosamines and Nutrient Sensing Endocrinology, June 1, 2000; 141(6): 1922 - 1925. [Full Text] [PDF]